Merck & Co Inc (MRK)
121.44
-0.08
(-0.07%)
USD |
NYSE |
Mar 18, 16:00
121.64
+0.20
(+0.16%)
Pre-Market: 06:29
Merck Revenue (TTM): 60.11B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 60.11B |
September 30, 2023 | 59.31B |
June 30, 2023 | 58.31B |
March 31, 2023 | 57.87B |
December 31, 2022 | 59.28B |
September 30, 2022 | 58.97B |
June 30, 2022 | 57.17B |
March 31, 2022 | 53.98B |
December 31, 2021 | 48.70B |
September 30, 2021 | 46.13B |
June 30, 2021 | 43.91B |
March 31, 2021 | 41.86B |
December 31, 2020 | 43.29B |
September 30, 2020 | 36.49B |
June 30, 2020 | 37.96B |
March 31, 2020 | 40.36B |
December 31, 2019 | 39.12B |
September 30, 2019 | 45.97B |
June 30, 2019 | 44.37B |
March 31, 2019 | 43.07B |
December 31, 2018 | 42.29B |
September 30, 2018 | 41.73B |
June 30, 2018 | 41.26B |
March 31, 2018 | 40.72B |
December 31, 2017 | 40.12B |
Date | Value |
---|---|
September 30, 2017 | 39.80B |
June 30, 2017 | 40.02B |
March 31, 2017 | 39.93B |
December 31, 2016 | 39.81B |
September 30, 2016 | 39.91B |
June 30, 2016 | 39.44B |
March 31, 2016 | 39.38B |
December 31, 2015 | 39.50B |
September 30, 2015 | 39.76B |
June 30, 2015 | 40.25B |
March 31, 2015 | 41.40B |
December 31, 2014 | 42.24B |
September 30, 2014 | 43.08B |
June 30, 2014 | 43.55B |
March 31, 2014 | 43.63B |
December 31, 2013 | 44.03B |
September 30, 2013 | 44.45B |
June 30, 2013 | 44.91B |
March 31, 2013 | 46.21B |
December 31, 2012 | 47.27B |
September 30, 2012 | 47.82B |
June 30, 2012 | 48.36B |
March 31, 2012 | 48.20B |
December 31, 2011 | 48.05B |
September 30, 2011 | 47.85B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
36.49B
Minimum
Sep 2020
60.11B
Maximum
Dec 2023
48.81B
Average
46.05B
Median
Revenue (TTM) Benchmarks
Amgen Inc | 28.19B |
Gilead Sciences Inc | 27.12B |
Johnson & Johnson | 93.02B |
Harpoon Therapeutics Inc (DELISTED) | 37.34M |
Moderna Inc | 6.754B |